Ted Tarasow

HealthTell, Inc. develops healthcare diagnosing tools for individuals to monitor their health status. It offers OneTest, a new technology for the early detection and monitoring of progressive diseases and the test is simple and inexpensive, and can be performed with only a single drop of blood. The company was founded in 2010 by Stephen Albert Johnston and Neal Woodbury and is headquartered in Chandler, AZ.

HealthTell, Inc. develops healthcare diagnosing tools for individuals to monitor their health status. It offers OneTest, a new technology for the early detection and monitoring of progressive diseases and the test is simple and inexpensive, and can be performed with only a single drop of blood. The company was founded in 2010 by Stephen Albert Johnston and Neal Woodbury and is headquartered in Chandler, AZ.

HealthTell, Inc. develops healthcare diagnosing tools for individuals to monitor their health status. It offers OneTest, a new technology for the early detection and monitoring of progressive diseases and the test is simple and inexpensive, and can be performed with only a single drop of blood. The company was founded in 2010 by Stephen Albert Johnston and Neal Woodbury and is headquartered in Chandler, AZ.

Vanquish Oncology, Inc. operates as a drug development company. It focused on targeting molecular defects in specific cancer cells to create personalized oncology therapeutics for unmet and underserved cancer markets. The company was founded by Paul J. Hergenrother, Mike Handley and Ted Tarasow and is headquartered in Champaign, IL.

Transverse Medical, Inc. develops Point-Guard, a cerebral embolic protection device. The firm specializes in cerebral embolic protection, transcatheter aortic valve, surgical aortic valve and medical device development. The company was founded in 2011 and is headquartered in Golden, CO.

Transverse Medical, Inc. develops Point-Guard, a cerebral embolic protection device. The firm specializes in cerebral embolic protection, transcatheter aortic valve, surgical aortic valve and medical device development. The company was founded in 2011 and is headquartered in Golden, CO.

Transverse Medical, Inc. develops Point-Guard, a cerebral embolic protection device. The firm specializes in cerebral embolic protection, transcatheter aortic valve, surgical aortic valve and medical device development. The company was founded in 2011 and is headquartered in Golden, CO.

Transverse Medical, Inc. develops Point-Guard, a cerebral embolic protection device. The firm specializes in cerebral embolic protection, transcatheter aortic valve, surgical aortic valve and medical device development. The company was founded in 2011 and is headquartered in Golden, CO.

Vanquish Oncology, Inc. operates as a drug development company. It focused on targeting molecular defects in specific cancer cells to create personalized oncology therapeutics for unmet and underserved cancer markets. The company was founded by Paul J. Hergenrother, Mike Handley and Ted Tarasow and is headquartered in Champaign, IL.

Vanquish Oncology, Inc. operates as a drug development company. It focused on targeting molecular defects in specific cancer cells to create personalized oncology therapeutics for unmet and underserved cancer markets. The company was founded by Paul J. Hergenrother, Mike Handley and Ted Tarasow and is headquartered in Champaign, IL.